ProCE Banner Series

Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis

Join us for a series of three live, virtual 60-minute CME/CE-certified webinars focused on clinical decision-making with IL-13 inhibitors in moderate to severe atopic dermatitis. Through interactive, case-based discussions, expert faculty will share practical insights and real-world strategies. Participants will also have the opportunity to pose questions directly to the panel and engage in thoughtful dialogue

  AAPA
  | AMA
  | ANCC
Who Should Attend

This education is intended for dermatologists, allergist/immunologists, and nurse practitioners (NPs) and physician associates (PAs) practicing in dermatology and allergy who manage patients with moderate to severe atopic dermatitis.

All Events

Upcoming Events

June

16

2025

Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

June

20

2025

Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis

11:00 AM - 12:00 PM Eastern Time (ET)

Virtual

June

23

2025

Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis

11:00 AM - 12:00 PM Eastern Time (ET)

Virtual

Past Events

March

09

2025

Team Trivia! Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis

7:00 PM - 9:00 PM Eastern Time (ET)

In-person

Hilton Orlando, 6001 Destination Parkway, Orlando, Florida 32819

7:30 PM - 9:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

This program is independent and is not part of the official AAD Annual Meeting, as planned by its Scientific Assembly Committee.

This program does not qualify for Continuing Medical Education (CME) Credit.

Goal Statement
The goal of this educational activity is to improve learners’ knowledge, competence, and performance managing advanced therapy for patients with moderate to severe atopic dermatitis.

Target Audience
This education is intended for dermatologists, allergist/immunologists, and nurse practitioners (NPs) and physician associates (PAs) practicing in dermatology and allergy who manage patients with moderate to severe atopic dermatitis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Understand the pathophysiologic contributions of IL-13 in promoting the clinical manifestations of moderate to severe AD

  • Evaluate available evidence and current guidelines to differentiate advanced therapies targeting IL-13 in moderate to severe AD

  • Assess patient candidacy for advanced biologic therapies targeting IL-13 in moderate to severe AD

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association

This activity is supported by an educational grant from Lilly.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191